Key terms
About SPRC
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SPRC news
Apr 11
4:27pm ET
SciSparc Announces Strategic Merger with Automax Motors
Apr 11
8:18am ET
SciSparc enters merger agreement with AutoMax Motors
Mar 27
8:56am ET
SciSparc says Clearmind submits international patent application for depression
Mar 21
9:04am ET
SciSparc announces MitoCareX Bio virtually screened molecules using platform
Mar 18
7:36am ET
SciSparc granted patent for core-technology
Mar 12
8:39am ET
SciSparc says MitoCareX reveals millions of small molecules virtually screened
Mar 08
7:13am ET
SciSparc announces enrollment of first patient in trial for children with ASD
Mar 07
8:04am ET
SciSparc granted patent for core technology in jurisdictions in Europe
Mar 06
4:42pm ET
SciSparc awarded Canadian patent for opioids reduction use
Feb 29
8:46am ET
SciSparc delivers treatment for ASD trial enabling commencement of dosing
Feb 27
4:25pm ET
SciSparc files to sell 5.4M ordinary shares for holders
Feb 27
8:02am ET
Clearmind Medicine submits three additional international patent applications
Feb 27
7:59am ET
SciSparc says Clearmind files three new international patent applications
Feb 20
7:17am ET
SciSparc announces Clearmind filed three patents
Feb 20
7:16am ET
Clearmind Medicine submits three international patent applications
Jan 24
7:43am ET
SciSparc announces $20M standby equity purchase agreement
Jan 19
9:30am ET
SciSparc enters into bridge loan agreement with vehicle importer in Israel
No recent press releases are available for SPRC
SPRC Financials
Key terms
Ad Feedback
SPRC Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SPRC Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
